BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 17398147)

  • 1. The error negativity in nonmedicated and medicated patients with Parkinson's disease.
    Stemmer B; Segalowitz SJ; Dywan J; Panisset M; Melmed C
    Clin Neurophysiol; 2007 Jun; 118(6):1223-9. PubMed ID: 17398147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. To the influence of general slowing and medication on identity- and location-based priming effects in patients with Parkinson's disease.
    Troche SJ; Trenkwalder C; Morelli-Canelo M; Gibbons H; Rammsayer TH
    J Neuropsychol; 2009 Sep; 3(Pt 2):147-68. PubMed ID: 19338711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance monitoring and error processing during a lexical decision task in patients with Parkinson's disease.
    Ito J; Kitagawa J
    J Geriatr Psychiatry Neurol; 2006 Mar; 19(1):46-54. PubMed ID: 16449761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of aging, Parkinson's disease, and dopaminergic medication on response selection and control.
    Willemssen R; Falkenstein M; Schwarz M; Müller T; Beste C
    Neurobiol Aging; 2011 Feb; 32(2):327-35. PubMed ID: 19269061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motor procedural learning in Parkinson's disease.
    Muslimovic D; Post B; Speelman JD; Schmand B
    Brain; 2007 Nov; 130(Pt 11):2887-97. PubMed ID: 17855374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basal ganglia, dopamine and temporal processing: performance on three timing tasks on and off medication in Parkinson's disease.
    Jones CR; Malone TJ; Dirnberger G; Edwards M; Jahanshahi M
    Brain Cogn; 2008 Oct; 68(1):30-41. PubMed ID: 18378374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic modulation of performance monitoring in Parkinson's disease: An event-related potential study.
    Seer C; Lange F; Loens S; Wegner F; Schrader C; Dressler D; Dengler R; Kopp B
    Sci Rep; 2017 Jan; 7():41222. PubMed ID: 28117420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Parkinson's disease and dopaminergic medication on proprioceptive processing.
    Mongeon D; Blanchet P; Messier J
    Neuroscience; 2009 Jan; 158(2):426-40. PubMed ID: 18996173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Error processing in patients with Parkinson's disease: the influence of medication state.
    Willemssen R; Müller T; Schwarz M; Hohnsbein J; Falkenstein M
    J Neural Transm (Vienna); 2008; 115(3):461-8. PubMed ID: 18250959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involuntary attention impairment in early Parkinson's disease: an event-related potential study.
    Solís-Vivanco R; Ricardo-Garcell J; Rodríguez-Camacho M; Prado-Alcalá RA; Rodríguez U; Rodríguez-Violante M; Rodríguez-Agudelo Y
    Neurosci Lett; 2011 May; 495(2):144-9. PubMed ID: 21443924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response inhibition subprocesses and dopaminergic pathways: basal ganglia disease effects.
    Beste C; Willemssen R; Saft C; Falkenstein M
    Neuropsychologia; 2010 Jan; 48(2):366-73. PubMed ID: 19782093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are dopaminergic pathways involved in theory of mind? A study in Parkinson's disease.
    Péron J; Vicente S; Leray E; Drapier S; Drapier D; Cohen R; Biseul I; Rouaud T; Le Jeune F; Sauleau P; Vérin M
    Neuropsychologia; 2009 Jan; 47(2):406-14. PubMed ID: 18845171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advance preparation of set-switches in Parkinson's disease.
    Pollux PM
    Neuropsychologia; 2004; 42(7):912-9. PubMed ID: 14998705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haloperidol impairs learning and error-related negativity in humans.
    Zirnheld PJ; Carroll CA; Kieffaber PD; O'Donnell BF; Shekhar A; Hetrick WP
    J Cogn Neurosci; 2004; 16(6):1098-112. PubMed ID: 15298795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Error processing in normal aging and in basal ganglia disorders.
    Beste C; Willemssen R; Saft C; Falkenstein M
    Neuroscience; 2009 Mar; 159(1):143-9. PubMed ID: 19166908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine asymmetry interacts with medication to affect cognition in Parkinson's disease.
    Tomer R; Aharon-Peretz J; Tsitrinbaum Z
    Neuropsychologia; 2007 Jan; 45(2):357-67. PubMed ID: 16876208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Error-processing deficits in patients with cocaine dependence.
    Franken IH; van Strien JW; Franzek EJ; van de Wetering BJ
    Biol Psychol; 2007 Apr; 75(1):45-51. PubMed ID: 17196732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emotion processing in Parkinson's disease: dissociation between early neuronal processing and explicit ratings.
    Wieser MJ; Mühlberger A; Alpers GW; Macht M; Ellgring H; Pauli P
    Clin Neurophysiol; 2006 Jan; 117(1):94-102. PubMed ID: 16330254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the error-related negativity amplitude related to error detectability? Evidence from effects of different error types.
    Maier M; Steinhauser M; Hübner R
    J Cogn Neurosci; 2008 Dec; 20(12):2263-73. PubMed ID: 18457501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Error positivity is related to attentional control of task switching.
    Tanaka H
    Neuroreport; 2009 May; 20(8):820-4. PubMed ID: 19384255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.